Seroconversion Across Multiple News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ADMA Biologics Presents Late-Breaking Poster Presentation Highlighting Clinical Utility of S. ... ADMA Biologics, Inc.February 26, 2021 GMT Poster Presentation Highlights the Need for a Polyclonal Hyperimmune Globulin Targeting S. Pneumoniae to Bridge Vaccination and Seroconversion Across Multiple Serotypes By Using as an Add-On with a Vaccine or Antibiotics, This Therapeutic Strategy has the Potential to Improve S. Pneumoniae -Related Hospital Clinical Outcomes RAMSEY, N.J. and BOCA RATON, Fla., ...

Session Dates: Friday, February 26 – Monday, March 1, 2021 Session Location: Virtual Poster Hall Poster No: L30 About ADMA Biologics, Inc. ADMA Biologics is an end-to-end American commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies a...